The company
Clearmind Medicine Inc. - Common Shares
CMND · Nasdaq
CMND stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 79.1% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−12 points in four weeks); Health Care: 28% (−6 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 52
- Industry in uptrend
- 18% -12 in 4 wk
- Insider buys, 12 months
- $654K
- Insider sales, 12 months
- $236K
- Officials’ trades on record
- 0
- Institutions holding
- 5 (+2)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Hrt Financial Lp10% owner | sold | 22,139at $3.31 | 16 Jun 2026filed 18 Jun 2026 |
| Hrt Financial Lp10% owner | sold | 3,183at $3.32 | 15 Jun 2026filed 17 Jun 2026 |
| Hrt Financial Lp10% owner | sold | 2,102at $3.36 | 12 Jun 2026filed 16 Jun 2026 |
| Hrt Financial Lp10% owner | sold | 225,191at $0.123 | 11 Jun 2026filed 12 Jun 2026 |
| Hrt Financial Lp10% owner | bought | 2,159,052at $0.153 | 10 Jun 2026filed 12 Jun 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| CITADEL ADVISORS LLCnew · filed 14 Aug 2026 | 11,710$26K | +11,710 |
| AdvisorShares Investments LLCreduced · filed 11 Aug 2026 | 1,169$2,572 | -6,188−84.1% |
| MORGAN STANLEYnew · filed 13 Aug 2026 | 700$1,540 | +700 |
| Caitong International Asset Management Co., Ltdnew · filed 5 Aug 2026 | 1$2 | +1 |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.